Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.47 |
| ▸ | MMP2 | P08253 | 2/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7605379 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5181134 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5180295 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL7612414 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5180613 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL2515904 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL9324206 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL543555 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL5180208 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL2513516 | 1.00 | GPR84 (0.55) | GPR84FFAR1FFAR4PSMD14PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8313755-B2 | Long-chain fatty acid having 12 to 24 carbon atoms, a nonionic surface active agent; cosmetics, bath agents, hair-care products, external preparations for the skin | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-11-20 | — | — | US | disclosed |
| EP-1153595-B1 | Clear aqueous ceramide composition | TAKASAGO PERFUMERY CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| EP-1254651-B1 | Use of fragrance retaining composition | TAKASAGO PERFUMERY CO LTD (JP) | 2007-12-12 | — | — | EP | disclosed |
| EP-1254651-A1 | Fragrance retaining composition and use | Takasago International Corporation (JP) | 2002-11-06 | — | — | EP | disclosed |
| US-20020010215-A1 | Clear aqueous ceramide composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1153595-A2 | Clear aqueous ceramide composition | Takasago International Corporation (JP) | 2001-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010215-A1 | Clear aqueous ceramide composition | CERS2, CERT1, SGMS1 | GPR84 817/4885FFAR1 50/4885FFAR4 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.